Research shows rapid adoption of newer, more expensive prostate cancer treatments – With 180,000 men diagnosed with prostate cancer each year, it is one of the most common types of cancer in US. For this reason, it has been cited as a good marker for health care spending in general, reflective of the greater trends across the United States.
Follow-Up Program Helps Detect Melanoma Earlier in High-Risk Patients – A follow-up program for patients at high risk of developing skin cancer appears to be associated with the detection of melanomas at early stages and with good prognosis.
Age plays too big a role in prostate cancer treatment decisions – Older men with high-risk prostate cancer frequently are offered fewer ? and less effective ? choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.
FDA: Gardasil approved to prevent anal cancer – The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.
Cost of prostate cancer care varies with initial treatment choice – A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives.
Rectal cancer rates are rising in young individuals – A new analysis has found that while colon cancer rates have remained steady over the past several decades among people under the age of 40, rectal cancer rates are increasing in this population across races and in both sexes.
Miami meeting on radiation therapy targets patient safety — Gathering brings clinicians, manufacturers, regulators, hospital administrators and public interest groups together to discuss new ways of avoiding errors – A meeting in Miami this week will bring together some of the world’s leading experts from inside and outside the clinic to discuss safety in radiation therapy — a critical method for treating cancer.
Researchers found that a single dose of radiation during surgery is just as effective as a prolonged course of radiotherapy for breast cancer. – The researchers from an international TARGIT research group found a new method of radiotherapy for breast cancer in which the treatment can be reduced to a single radiation exposure.
Nanoparticle PSA test predicts if prostate cancer will return — Ultrasensitive test gives first accurate answer after prostate cancer surgery – New research from Northwestern University Feinberg School of Medicine and the University International Institute for Nanotechnology shows that an ultrasensitive PSA test using nanoparticle-based technology (VeriSens? PSA, Nanosphere, Inc., research-use-only) may be able to definitively predict after surgery if the cancer is cured long term or if it will recur.
Patients who refuse prostate cancer surgery have worse long-term survival – Men who refuse surgery for prostate cancer and instead opt for “watchful waiting” ? monitoring cancer progression without undergoing treatment ? have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.
Blood flows differently through the brains of schizophrenic patients – Researchers in Germany have used a magnetic resonance imaging (MRI) technique called continuous arterial spin labeling (CASL) to map cerebral blood flow patterns in schizophrenic patients quickly and without using radiation or contrast agents. Their findings appear in the online edition and July printed issue of the journal Radiology.
Exercise may keep cancer patients healthier during, after treatment – Breast and prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued, according to researchers at Henry Ford Hospital in Detroit.
